COYA Coya Therapeutics, Inc.
Healthcare$4.71-2.08%ClosedMarket Cap: $85.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
11.03
EV/EBITDA
2317.64
DCF Value
$4.97
FCF Yield
-16.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.8%
Operating Margin
-277.0%
Net Margin
-266.1%
ROE
-0.2%
ROA
-0.0%
ROIC
-0.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $251.1K | 98.9% | $-7.6M | $-7.2M | $— | — |
| Q4 null | $4.0M | 100.0% | $-6.0M | $-5.7M | $— | — |
| FY null | $7.9M | 99.7% | $-20.3M | $-21.2M | $— | — |
| Q3 null | $3.6M | 99.8% | $-1.9M | $-2.1M | $— | — |
| Q2 null | $163.6K | 95.8% | $-6.4M | $-6.1M | $— | — |
| Q1 null | $257.9K | -1921.9% | $-7.7M | $-7.3M | $— | — |
| Q4 null | $2.0K | -99154.1% | $-4.1M | $-2.9M | $— | — |
| FY null | $3.6M | -233.9% | $-17.2M | $-14.9M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-4.5M | $-4.0M | $— | — |
| Q2 null | $3.4M | -33.3% | $-3.2M | $-2.9M | $— | — |
| Q1 null | $126.8K | -2374.1% | $-5.5M | $-5.1M | $— | — |
| Q4 2023 | $6.0M | 73.2% | $1.8M | $1.3M | $0.12 | — |